Double Medical(SZ:002901) Sou Hu Cai Jing·2025-09-05 13:02Core Viewpoint - Dabo Medical (002901) shows a positive performance with a closing price of 54.39 yuan, up 1.76% as of September 5, 2025, despite some net outflows from major and retail investors [1] Financial Performance - Dabo Medical reported a main revenue of 1.21 billion yuan for the first half of 2025, an increase of 25.55% year-on-year [3] - The net profit attributable to shareholders reached 244 million yuan, up 76.69% year-on-year [3] - The net profit excluding non-recurring items was 223 million yuan, reflecting an increase of 82.64% year-on-year [3] - In Q2 2025, the company achieved a single-quarter main revenue of 660 million yuan, up 22.96% year-on-year [3] - The single-quarter net profit attributable to shareholders was 141 million yuan, up 84.47% year-on-year [3] - The single-quarter net profit excluding non-recurring items was 126 million yuan, up 73.04% year-on-year [3] Market Position - Dabo Medical's total market capitalization is 22.519 billion yuan, ranking 11th in the medical device industry [3] - The company's net assets stand at 3.233 billion yuan, ranking 45th in the industry [3] - The net profit margin is 21.42%, ranking 33rd in the industry [3] - The company has a gross margin of 71.01%, significantly higher than the industry average of 51.85% [3] - The price-to-earnings ratio (P/E) is 46.1, which is lower than the industry average of 65.4 [3] Investor Sentiment - As of the last 90 days, one institution has given a buy rating for Dabo Medical [4]